AU721943B2 - Method for treating or preventing ischemia-reperfusion injury - Google Patents

Method for treating or preventing ischemia-reperfusion injury Download PDF

Info

Publication number
AU721943B2
AU721943B2 AU27405/97A AU2740597A AU721943B2 AU 721943 B2 AU721943 B2 AU 721943B2 AU 27405/97 A AU27405/97 A AU 27405/97A AU 2740597 A AU2740597 A AU 2740597A AU 721943 B2 AU721943 B2 AU 721943B2
Authority
AU
Australia
Prior art keywords
ischemia
repair
reperfusion injury
injury
caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU27405/97A
Other languages
English (en)
Other versions
AU2740597A (en
Inventor
Timothy R. S. Harward
Lyle L. Moldawer
Satwant K Narula
James M. Seeger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2740597A publication Critical patent/AU2740597A/en
Application granted granted Critical
Publication of AU721943B2 publication Critical patent/AU721943B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
AU27405/97A 1996-05-02 1997-05-01 Method for treating or preventing ischemia-reperfusion injury Ceased AU721943B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64185996A 1996-05-02 1996-05-02
US08/641859 1996-05-02
PCT/US1997/006809 WO1997040849A1 (fr) 1996-05-02 1997-05-01 Procede de traitement ou de prevention des lesions lors d'une reperfusion au cours d'une ischemie

Publications (2)

Publication Number Publication Date
AU2740597A AU2740597A (en) 1997-11-19
AU721943B2 true AU721943B2 (en) 2000-07-20

Family

ID=24574163

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27405/97A Ceased AU721943B2 (en) 1996-05-02 1997-05-01 Method for treating or preventing ischemia-reperfusion injury

Country Status (9)

Country Link
EP (1) EP0906117A1 (fr)
JP (1) JP2000509073A (fr)
KR (1) KR20000065178A (fr)
AU (1) AU721943B2 (fr)
BR (1) BR9709752A (fr)
CA (1) CA2253313A1 (fr)
IL (1) IL126657A0 (fr)
NZ (1) NZ332412A (fr)
WO (1) WO1997040849A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113629A (en) * 1998-05-01 2000-09-05 Micrus Corporation Hydrogel for the therapeutic treatment of aneurysms
JP2002532556A (ja) * 1998-12-22 2002-10-02 シェリング・コーポレーション Ｃ型肝炎ウイルス感染のインターロイキン−１０での処置
WO2001006262A1 (fr) * 1999-02-19 2001-01-25 University Of Iowa Research Foundation Agents diagnostiques et therapeutiques appliques a la degenerescence de la macula
US7108982B1 (en) 1999-02-19 2006-09-19 University Of Iowa Research Foundation Diagnostics and the therapeutics for macular degeneration
JP2006524701A (ja) * 2003-04-25 2006-11-02 ミトス・インコーポレーテッド 酸化防止剤による予防的前処置
JP6999664B2 (ja) 2016-10-31 2022-01-18 サムスン ライフ パブリック ウェルフェア ファウンデーション 胆汁酸を含む虚血性再灌流損傷の予防または治療用薬学的組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9508243A (pt) * 1994-07-05 1997-10-21 Steeno Res Group As Imunomoduladores

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EUROPEAN HEART JOUR. 15 (ABSTR SUPPL) 1994. 471 XP002035704 *

Also Published As

Publication number Publication date
WO1997040849A1 (fr) 1997-11-06
BR9709752A (pt) 1999-08-10
CA2253313A1 (fr) 1997-11-06
JP2000509073A (ja) 2000-07-18
NZ332412A (en) 2000-05-26
AU2740597A (en) 1997-11-19
IL126657A0 (en) 1999-08-17
KR20000065178A (ko) 2000-11-06
EP0906117A1 (fr) 1999-04-07

Similar Documents

Publication Publication Date Title
RU2166955C2 (ru) Способ лечения и профилактики заболеваний, обусловленных повышением уровня фактора, вызывающего некроз опухолевых клеток
AU672606B2 (en) Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
CA2741302C (fr) Polypeptide inhibiteur de la kinase mapkap destine au traitement ou a la prevention des adherences
JP2000511190A (ja) 外傷に起因する出血に見舞われたヒトにおけるｂｐｉタンパク質産物の治療用途
Block et al. Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia.
JP2002532556A (ja) Ｃ型肝炎ウイルス感染のインターロイキン−１０での処置
US7645733B2 (en) Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
AU721943B2 (en) Method for treating or preventing ischemia-reperfusion injury
US6086868A (en) Method for treating or preventing ischemia-reperfusion injury
JP5420151B2 (ja) 炎症におけるｉｌ−１８結合性タンパク質の使用
JP2002371006A (ja) 肺線維症予防および／または進行防止剤
EP1058544B1 (fr) Inhibition de l'activite du tnf avec des compositions pharmaceutiques comprenant de l'heparine et les recepteurs solubles du tnf
MXPA98008946A (en) Method of treatment or prevention of the injury caused by isquemia-reperfus
MIYAGAWA et al. Epidermolysis bullosa acquisita with oesophageal stenosis
JP4023863B2 (ja) Ｉｌ−６を含む血清尿酸値低下剤
EP1948216B1 (fr) Traitement d'une insuffisance renale aigue avec la thrombomoduline soluble
WO1999027951A1 (fr) Preparation pour l'admission intraveineuse continue
JPH083065A (ja) 肝臓障害に対する治療剤
CA1066620A (fr) Melange de proteines extraites du foie et methode d'utilisation
CN1223587A (zh) 治疗或预防局部缺血－再灌注损伤的方法
Block et al. Endogenous D‐factor activity partially mediates the toxic but not the therapeutic effects of tumor necrosis factor
CA2376358A1 (fr) Utilisation d'interleukine-11 dans le traitement du choc hemorragique
LeRoy et al. PROTEINASES IN THE FIBROSIS OF SYSTEMIC SCLEROSIS
WO2004071429A2 (fr) Traitement d'une inflammation pulmonaire

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired